← All candidates
63 insider filings on record.
63 filings on record.
DVADAVITA INC.
NYSE · Healthcare · $12.37B
$193.86
+1.55% · Sep 16
63 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 7 sells
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$12.37B
Float
33.9M
53% public
Short % float
Pro
Price / profit
16.2
Price / future profit
11.2
Price / sales
0.9
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
58 more transactions on Pro →Context
Wall St
$193.71 avg target
-0.1% vs today · 7 analysts
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
3 of 4 quarters beat
Q1 '26$2.87 act+$0.54
Q4 '25$3.40 act+$0.21
Q3 '25$2.51 act−$0.66
Q2 '25$2.95 act+$0.20
Coverage
DaVita (DVA) Stock Could Be 19% Overvalued Despite Strong Q1 ResultsSimply Wall St. · 07-04Is DaVita Inc. (DVA) A Good Stock To Buy Now?Insider Monkey · 07-03DaVita (DVA) Expands Integrated Kidney Care With AI Tools For Dialysis CareSimply Wall St. · 07-03Should Value Investors Buy DaVita (DVA) Stock?Zacks · 07-02
The file stays open
63 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice